Vontobel Holding’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.32M Sell
54,103
-7,135
-12% -$693K 0.02% 430
2026
Q2
$5.7M Sell
61,238
-31,869
-34% -$3M 0.02% 427
2026
Q1
$8.28M Buy
93,107
+10,885
+13% +$1.12M 0.03% 286
2025
Q4
$7.83M Buy
82,222
+10,126
+14% +$1.02M 0.02% 320
2025
Q3
$7.11M Buy
72,096
+12,124
+20% +$1.3M 0.02% 310
2025
Q2
$6.39M Buy
59,972
+38,090
+174% +$3.85M 0.02% 326
2025
Q1
$1.99M Buy
21,882
+497
+2% +$55.6K 0.01% 444
2024
Q4
$2.44M Buy
21,385
+4,227
+25% +$482K 0.01% 412
2024
Q3
$2.04M Sell
17,158
-28,574
-62% -$2.63M 0.01% 443
2024
Q2
$3.68M Sell
45,732
-1,949
-4% -$178K 0.01% 346
2024
Q1
$4.4M Buy
47,681
+6,148
+15% +$590K 0.04% 324
2023
Q4
$4.38M Sell
41,533
-21,125
-34% -$2.13M 0.04% 319
2023
Q3
$6.81M Sell
62,658
-32,256
-34% -$3.57M 0.06% 250
2023
Q2
$10.2M Sell
94,914
-24,362
-20% -$2.74M 0.09% 206
2023
Q1
$14.9M Buy
119,276
+110,526
+1,263% +$15.2M 0.14% 160
2022
Q4
$1.33M Buy
8,750
+2,927
+50% +$450K 0.01% 507
2022
Q3
$786K Sell
5,823
-234
-4% -$35.8K 0.01% 593
2022
Q2
$860K Buy
+6,057
New +$925K 0.01% 578

Other funds holding BNTX

Vontobel Holding's BNTX Position: Q3 2026 in Review

Vontobel Holding reduced its BioNTech (BNTX) stake by 12% in Q3 2026, selling an estimated $693K and leaving 54,103 shares worth $5.32M. The position accounts for 0.02% of the portfolio, ranked #430.

Vontobel Holding first reported a position in BNTX in Q2 2022 and has held it in 18 quarters since. The position peaked at $14.9M in Q1 2023. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Vontobel Holding held 54,103 shares of BioNTech worth $5.32M as of Q3 2026.
  • Vontobel Holding sold 7,135 BioNTech shares in Q3 2026, an estimated $693K.
  • BioNTech made up 0.02% of Vontobel Holding's portfolio in Q3 2026, its #430 holding.
  • Vontobel Holding first reported a position in BioNTech in Q2 2022 and has held it in 18 quarters since.
  • Vontobel Holding's BioNTech position peaked at $14.9M in Q1 2023.
  • 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.